Leptin: an entry point for the treatment of peripheral tissue fibrosis and related diseases
- 15 February 2022
- journal article
- research article
- Published by Elsevier in International Immunopharmacology
- Vol. 106, 108608
Abstract
No abstract availableKeywords
This publication has 111 references indexed in Scilit:
- Pulmonary fibrosis: patterns and perpetratorsJournal of Clinical Investigation, 2012
- Adiponectin inhibits leptin signalling via multiple mechanisms to exert protective effects against hepatic fibrosisBiochemical Journal, 2011
- Leptin Action on GABAergic Neurons Prevents Obesity and Reduces Inhibitory Tone to POMC NeuronsNeuron, 2011
- Obesity, diabetes mellitus, and liver fibrosisAmerican Journal of Physiology-Gastrointestinal and Liver Physiology, 2011
- Adiponectin activation of AMPK disrupts leptin‐mediated hepatic fibrosis via suppressors of cytokine signaling (SOCS‐3)Journal of Cellular Biochemistry, 2010
- Interleukin-10 Prevents Diet-Induced Insulin Resistance by Attenuating Macrophage and Cytokine Response in Skeletal MuscleDiabetes, 2009
- Kupffer Cells Mediate Leptin-Induced Liver FibrosisGastroenterology, 2009
- Hypothalamic IKKβ/NF-κB and ER Stress Link Overnutrition to Energy Imbalance and ObesityCell, 2008
- Hedgehog: functions and mechanismsGenes & Development, 2008
- Mutations affecting segment number and polarity in DrosophilaNature, 1980